Literature DB >> 29146293

Andrographolide - A promising therapeutic agent, negatively regulates glial cell derived neurodegeneration of prefrontal cortex, hippocampus and working memory impairment.

Sudeshna Das1, K P Mishra1, Lilly Ganju1, S B Singh2.   

Abstract

Over activation of glial cell derived innate immune factors induces neuro-inflammation that results in neurodegenerative disease, like working memory impairment. In this study, we have investigated the role of andrographolide, a major constituent of Andrographis paniculata plant, in reduction of reactive glial cell derived working memory impairment. Real time PCR, Western bloting, flow cytometric and immunofluorescence studies demonstrated that andrographolide inhibited lipopolysaccharide (LPS)-induced overexpression of HMGB1, TLR4, NFκB, COX-2, iNOS, and release of inflammatory mediators in primary mix glial culture, adult mice prefrontal cortex and hippocampus region. Active microglial and reactive astrocytic makers were also downregulated after andrographolide treatment. Andrographolide suppressed overexpression of microglial MIP-1α, P2X7 receptor and its downstream signaling mediators including-inflammasome NLRP3, caspase1 and mature IL-1β. Furthermore, in vivo maze studies suggested that andrographolide treatment reversed LPS-induced behavioural and working memory disturbances including regulation of expression of protein markers like PKC, p-CREB, amyloid beta, APP, p-tau, synapsin and PSD-95. Andrographolide, by lowering expression of pro apoptotic genes and enhancing the expression of anti-apoptotic gene showed its anti-apoptotic nature that in turn reduces neurodegeneration. Morphology studies using Nissl and FJB staining also showed the neuroprotective effect of andrographolide in the prefrontal cortex region. The above studies indicated that andrographolide prevented neuroinflammation-associated neurodegeneration and improved synaptic plasticity markers in cortical as well as hippocampal region which suggests that andrographolide could be a novel pharmacological countermeasure for the treatment of neuroinflammation and neurological disorders related to memory impairment.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Andrographolide; Glial cells; Innate immune receptors; Neuro-inflammation; Prefrontal cortex; Working memory

Mesh:

Substances:

Year:  2017        PMID: 29146293     DOI: 10.1016/j.jneuroim.2017.11.003

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  9 in total

1.  Andrographolide enhances hippocampal BDNF signaling and suppresses neuronal apoptosis, astroglial activation, neuroinflammation, and spatial memory deficits in a rat model of chronic cerebral hypoperfusion.

Authors:  Da-Peng Wang; Hang Yin; Qi Lin; Shu-Ping Fang; Jian-Hua Shen; Yi-Fang Wu; Shao-Hua Su; Jian Hai
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-06-11       Impact factor: 3.000

2.  Andrographolide: Regulating the Master Regulator NF-κB.

Authors:  K P Mishra
Journal:  Indian J Clin Biochem       Date:  2019-12-10

3.  Andrographolide Inhibits Mechanical and Thermal Hyperalgesia in a Rat Model of HIV-Induced Neuropathic Pain.

Authors:  Zhihua Yi; Shuai Ouyang; Congfa Zhou; Lihui Xie; Zhi Fang; Huilong Yuan; Jinpu Yang; Lifang Zou; Tianyu Jia; Shanhong Zhao; Lin Li; Liran Shi; Yun Gao; Guilin Li; Shuangmei Liu; Hong Xu; Changshui Xu; Chunping Zhang; Shangdong Liang
Journal:  Front Pharmacol       Date:  2018-06-11       Impact factor: 5.810

4.  Andrographolide Protects PC12 Cells Against β-Amyloid-Induced Autophagy-Associated Cell Death Through Activation of the Nrf2-Mediated p62 Signaling Pathway.

Authors:  Lili Gu; Qingqing Yu; Qin Li; Lingxi Zhang; Hong Lu; Xinyue Zhang
Journal:  Int J Mol Sci       Date:  2018-09-19       Impact factor: 5.923

5.  Andrographolide emeliorates maltol aluminium-induced neurotoxicity via regulating p62-mediated Keap1-Nrf2 pathways in PC12 cells.

Authors:  Jiaqi Lu; Lili Gu; Qin Li; Ningzi Wu; Hongxing Li; Xinyue Zhang
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

Review 6.  NLRP3-Mediated Inflammation in Atherosclerosis and Associated Therapeutics.

Authors:  Na Lu; Weijia Cheng; Dongling Liu; Gang Liu; Can Cui; Chaoli Feng; Xianwei Wang
Journal:  Front Cell Dev Biol       Date:  2022-04-13

Review 7.  Andrographolide, a natural anti-inflammatory agent: An Update.

Authors:  Xiaohong Li; Weichen Yuan; Jibiao Wu; Jianhua Zhen; Qihui Sun; Minmin Yu
Journal:  Front Pharmacol       Date:  2022-09-27       Impact factor: 5.988

8.  Successful Brain Delivery of Andrographolide Loaded in Human Albumin Nanoparticles to TgCRND8 Mice, an Alzheimer's Disease Mouse Model.

Authors:  Anna Rita Bilia; Pamela Nardiello; Vieri Piazzini; Manuela Leri; Maria Camilla Bergonzi; Monica Bucciantini; Fiorella Casamenti
Journal:  Front Pharmacol       Date:  2019-08-22       Impact factor: 5.810

Review 9.  Immunomodulatory Effects of Diterpenes and Their Derivatives Through NLRP3 Inflammasome Pathway: A Review.

Authors:  Muhammad Torequl Islam; Sanaa K Bardaweel; Mohammad S Mubarak; Wojciech Koch; Katarzyna Gaweł-Beben; Beata Antosiewicz; Javad Sharifi-Rad
Journal:  Front Immunol       Date:  2020-09-25       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.